RECURRENT PROSTATE ADENOCARCINOMA
Clinical trials for RECURRENT PROSTATE ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT PROSTATE ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT PROSTATE ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New radiation approach may offer shorter, safer treatment for recurrent prostate cancer
Disease control Recruiting nowThis study tests whether a precise, short-course radiation therapy (SBRT) works as well as a slightly longer radiation approach (hypofractionated radiotherapy) for prostate cancer that has come back or spread to a few spots after surgery. About 118 men with low PSA levels will be…
Matched conditions: RECURRENT PROSTATE ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 14, 2026 12:01 UTC
-
New combo therapy aims to halt return of prostate cancer
Disease control Recruiting nowThis study compares two radioactive drugs (225Ac-PSMA-617 and 177Lu-PSMA-617) given together with precise radiation therapy for prostate cancer that has returned and spread to a few spots in the body. About 107 adults with this type of cancer will receive one of the drugs plus ta…
Matched conditions: RECURRENT PROSTATE ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated May 13, 2026 16:00 UTC